Т1 mapping in the evaluation of the risk factors for diffuse myocardial fibrosis in essential arterial hypertension

Т1 mapping in the evaluation of the risk factors for diffuse myocardial fibrosis in essential arterial hypertension

Background: The assessment of diffuse myocardial fibrosis is necessary to plan the management of patients with various cardiovascular disorders, including hypertensive heart disease. The development of imaging techniques has enabled a non-invasive detection of left ventricular myocardial fibrosis by...

Full description

Bibliographic Details
Main Authors:	A. S. Abramenko, M. V. Vishnyakova Jr., M. V. Vishnyakova, O. M. Drapkina, A. N. Kaburova
Format:	Article
Language:	Russian
Published:	MONIKI 2020-12-01
Series:	Alʹmanah Kliničeskoj Mediciny
Subjects:	diffuse myocardial fibrosis cardiac mri myocardial т1 mapping
Online Access:	https://www.almclinmed.ru/jour/article/view/1399

Similar Items

Myocardial fibrosis: Current aspects of the problem
by: V N Karetnikova, et al.
Published: (2017-01-01)

MAGNETIC RESONANCE IMAGING IN THE DIAGNOSIS OF THE HEART LESIONS IN PATIENTS WITH ACROMEGALY
by: A. S. Abramenko, et al.
Published: (2016-02-01)

Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction
by: Clotilde Roy, et al.
Published: (2018-08-01)

Molecular Mechanisms of Myocardial Fibrosis Development
by: Rosin, Nicole
Published: (2014)

Metformin Attenuates Postinfarction Myocardial Fibrosis and Inflammation in Mice
by: Halyna Loi, et al.
Published: (2021-08-01)

Fibrosis biomarkers and global myocardial strain in the diagnosis and prediction of diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction
by: A. V. Osokina, et al.
Published: (2021-07-01)

Measurement of diffuse ventricular fibrosis with myocardial T1 in patients with atrial fibrillation
by: Jay A. Montgomery, MD, et al.
Published: (2016-02-01)

Correlation of serum miR-148b expression with myocardial injury and myocardial fibrosis in patients with myocardial infarction
by: Fang Wang, et al.
Published: (2017-07-01)

Role of microRNAs in cardiac hypertrophy, myocardial fibrosis and heart failure
by: De-li Dong, et al.
Published: (2011-06-01)

Effect of exogenous adiponectin on myocardial fibrosis in mice models with myocardial fibrosis
by: Feng-Lin Jin, et al.
Published: (2016-01-01)

Relationship between gut microbiota and markers of myocardial fibrosis in with chronic heart failure with preserved ejection fraction
by: A. N. Kaburova, et al.
Published: (2021-07-01)

MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1
by: Xiaoxiao Liu, et al.
Published: (2018-04-01)

The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy
by: Walace de Souza Pimentel, et al.
Published: (2012-09-01)

Novel Approaches in Cardiac Imaging for Non-invasive Assessment of Left Heart Myocardial Fibrosis
by: Giulia Elena Mandoli, et al.
Published: (2021-04-01)

Magnetic Resonance Imaging in Myocardial Fibrosis Related to Ischemic Events
by: Himcinschi Elisabeta, et al.
Published: (2017-09-01)

Glycolysis Inhibition Alleviates Cardiac Fibrosis After Myocardial Infarction by Suppressing Cardiac Fibroblast Activation
by: Zhi-Teng Chen, et al.
Published: (2021-09-01)

Effect of adjuvant Shenqi injection therapy on cardiac function and myocardial fibrosis in patients with refractory heart failure
by: San-Wu Wu, et al.
Published: (2018-04-01)

Wheat germ agglutinin staining as a suitable method for detection and quantification of fibrosis in cardiac tissue after myocardial infarction
by: B. Emde, et al.
Published: (2014-10-01)

Myocardial Fibrosis in the Pathogenesis, Diagnosis, and Treatment of Hypertrophic Cardiomyopathy
by: Zeyi Cheng, et al.
Published: (2021-05-01)

Early diagnosis of myocardial fibrosis in patients with epicardial obesity
by: O. V. Gritsenko, et al.
Published: (2021-04-01)

Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats
by: Chao-Feng Lin, et al.
Published: (2019-05-01)

A prospective study examining the role of myocardial Fibrosis in outcome following mitral valve repair IN DEgenerative mitral Regurgitation: rationale and design of the mitral FINDER study
by: Boyang Liu, et al.
Published: (2017-11-01)

Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro
by: Xiao J, et al.
Published: (2016-03-01)

Correlation between serum matrix metalloproteinase and myocardial fibrosis in heart failure patients with reduced ejection fraction: A retrospective analysis
by: Ömer Çelik, et al.
Published: (2020-10-01)

Biomarkers in patients with myocardial fibrosis
by: An Zhe, et al.
Published: (2017-10-01)

Treatment effect of Shenqi injection in patients with refractory heart failure and its influence on myocardial fibrosis
by: Xiao-Hong Zhang
Published: (2017-05-01)

Functional activity of gdТ-cells in atopic dermatitis
by: Ye. G. Chourina, et al.
Published: (2006-06-01)

Pharmacological Inhibition of Focal Adhesion Kinase Attenuates Cardiac Fibrosis in Mice Cardiac Fibroblast and Post-Myocardial-Infarction Models
by: Guang-Pu Fan, et al.
Published: (2015-09-01)

Myocardial fibrosis and atrial fibrillation
by: S. V. Grigoryan, et al.
Published: (2018-09-01)

Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation
by: Yue Cui, et al.
Published: (2018-04-01)

Mir-21 Promotes Cardiac Fibrosis After Myocardial Infarction Via Targeting Smad7
by: Jinxia Yuan, et al.
Published: (2017-08-01)

Myocardial bridging presenting as myocardial ischaemia induced cardiac arrest: a case report
by: Young-Jae Ki
Published: (2021-04-01)

Biomarkers of myocardial fibrosis and their genetic regulation in patients with heart failure
by: T. B. Pecherina, et al.
Published: (2020-11-01)

Predictors of myocardial fibrosis and loss of epicardial adipose tissue volume in the long-term period after myocardial infarction
by: O. L. Barbarash, et al.
Published: (2020-03-01)

Fibrosis after Myocardial Infarction: An Overview on Cellular Processes, Molecular Pathways, Clinical Evaluation and Prognostic Value
by: Renato Francesco Maria Scalise, et al.
Published: (2021-03-01)

Intraoperative Myocardial Protection: Where Are We Going in the Future?
by: Shawn J. Khan, et al.
Published: (2020-12-01)

Protective Effects of Sacubitril/Valsartan on Cardiac Fibrosis and Function in Rats With Experimental Myocardial Infarction Involves Inhibition of Collagen Synthesis by Myocardial Fibroblasts Through Downregulating TGF-β1/Smads Pathway
by: Meifang Wu, et al.
Published: (2021-05-01)

Exacerbated Cardiac Fibrosis in Apelin-deficient Mice post Myocardial Infarction is Associated with Vimentin and MicroRNA-378
by: Yang, Jennifer
Published: (2012)

Exacerbated Cardiac Fibrosis in Apelin-deficient Mice post Myocardial Infarction is Associated with Vimentin and MicroRNA-378
by: Yang, Jennifer
Published: (2012)

Yes-Associated Protein is Involved in Myocardial Fibrosis in Rats with Diabetic Cardiomyopathy
by: Hu M, et al.
Published: (2021-05-01)